Column Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$34.1K Hold
393
– – 0.01% 369
2023
Q2
$37.2K Hold
393
– – 0.01% 359
2023
Q1
$29.7K Sell
393
-56
-12% -$4.22K ﹤0.01% 392
2022
Q4
$34.5K Hold
449
– – 0.01% 351
2022
Q3
$30K Hold
449
– – 0.01% 334
2022
Q2
$23K Hold
449
– – ﹤0.01% 374
2022
Q1
$25K Hold
449
– – ﹤0.01% 373
2021
Q4
$23K Buy
449
+350
+354% +$17.2K ﹤0.01% 394
2021
Q3
$5K Hold
99
– – ﹤0.01% 547
2021
Q2
$6K Hold
99
– – ﹤0.01% 526
2021
Q1
$6K Buy
99
+56
+130% +$3.09K ﹤0.01% 516
2020
Q4
$2K Hold
43
– – ﹤0.01% 589
2020
Q3
$2K Sell
43
-19
-31% -$975 ﹤0.01% 583
2020
Q2
$3K Hold
62
– – ﹤0.01% 617
2020
Q1
$3K Hold
62
– – ﹤0.01% 529
2019
Q4
$3K Buy
+62
New +$3.2K ﹤0.01% 566

Other funds holding CAH

Column Capital Advisors's CAH Position: Q3 2023 in Review

Column Capital Advisors held its Cardinal Health (CAH) position steady in Q3 2023 at 393 shares worth $34.1K. The position accounts for 0.01% of the portfolio, ranked #369.

Column Capital Advisors first reported a position in CAH in Q4 2019 and has held it in 16 quarters since. The position peaked at $37.2K in Q2 2023. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Column Capital Advisors held 393 shares of Cardinal Health worth $34.1K as of Q3 2023.
  • Column Capital Advisors left its Cardinal Health share count unchanged in Q3 2023.
  • Cardinal Health made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #369 holding.
  • Column Capital Advisors first reported a position in Cardinal Health in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Cardinal Health position peaked at $37.2K in Q2 2023.
  • 948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.